The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

• Main Authors: Xuedong An (Author), Liyun Duan (Author), Yue Hong Zhang (Author), De Jin (Author), Shenghui Zhao (Author), Rong Rong Zhou (Author), Yingying Duan (Author), Fengmei Lian (Author), Xiaolin Tong (Author)
• Format: Book
• Published: BMC, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), first broke out in Wuhan, China, in 2019. SARS-CoV-2 develops many types of mutations (such as B.1.1.7), making diagnosis and treatment challenging. Although we now have a prelim...